User profiles for K. Dalal

Prof. Koustuv Dalal

Mid Sweden University
Verified email at miun.se
Cited by 18065

[HTML][HTML] Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for …

…, MM Constantin, CS Crowe, A Cucu, K Dalal… - The Lancet, 2019 - thelancet.com
Background Comprehensive and comparable estimates of health spending in each country
are a key input for health policy and planning, and are necessary to support the achievement …

ADAMTS‐4 and ADAMTS‐5: key enzymes in osteoarthritis

P Verma, K Dalal - Journal of cellular biochemistry, 2011 - Wiley Online Library
Osteoarthritis (OA) is a progressive disease of the joints characterized by degradation of
articular cartilage. Although disease initiation may be multi‐factorial, the cartilage destruction …

[HTML][HTML] Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on …

…, AFG Cicero, O Dadras, SMA Dahlawi, X Dai, K Dalal… - The Lancet, 2021 - thelancet.com
Background The rapid spread of COVID-19 renewed the focus on how health systems
across the globe are financed, especially during public health emergencies. Development …

[HTML][HTML] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

…, O Dadras, B Dagnew, X Dai, K Dalal… - The Lancet …, 2021 - thelancet.com
Background Regularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …

[PDF][PDF] LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

…, M Ricicova, L Devorkin, C Pritchard, A O'Neill, K Dalal… - Cell reports, 2022 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal
antibodies (mAbs) can reduce the risk of hospitalization from coronavirus disease 2019 (…

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

I Endo, M Gonen, AC Yopp, KM Dalal, Q Zhou… - Annals of …, 2008 - journals.lww.com
Background: Despite data suggesting a rising worldwide incidence, intrahepatic
cholangiocarcinoma (IHC) remains an uncommon disease. This study analyzes changes in IHC …

[HTML][HTML] Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel …

…, LT Cooper, M Cortinovis, JA Crump, K Dalal… - The lancet, 2017 - thelancet.com
Background National levels of personal health-care access and quality can be approximated
by measuring mortality rates from causes that should not be fatal in the presence of …

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre …

…, H Cichoz-Lach, L Clark, F Cummings, K Dalal… - The Lancet, 2022 - thelancet.com
Background Active-comparator trials are important to inform patient and physician choice.
We aimed to evaluate the efficacy and safety of monotherapy with either ustekinumab or …

Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk

KM Dalal, MW Kattan, CR Antonescu… - Annals of …, 2006 - journals.lww.com
Objective: To determine the prognostic significance of histologic subtype in a large series of
patients with primary liposarcoma (LS) and to construct a LS-specific postoperative …

Base-resolution models of transcription-factor binding reveal soft motif syntax

…, A Shrikumar, S Krueger, A Alexandari, K Dalal… - Nature …, 2021 - nature.com
The arrangement (syntax) of transcription factor (TF) binding motifs is an important part of the
cis-regulatory code, yet remains elusive. We introduce a deep learning model, BPNet, that …